Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FemAid is a digital health company dedicated to improving women's health through personalized, AI-driven insights and support, with a primary focus on menopause management. The company's platform allows users to track symptoms, receive tailored health recommendations, and access professional guidance to navigate hormonal transitions. By leveraging data analytics and clinical expertise, FemAid aims to bridge the gap in menopause care and empower women with actionable health information. The company operates at the intersection of FemTech and digital therapeutics, providing a comprehensive tool for symptom monitoring and lifestyle interventions. Its mission is to normalize the conversation around menopause and provide accessible, evidence-based care for women worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FemAid.